Relay Therapeutics is trading at $19.13, up 4.32%, in after-hours trading on October 22, 2026, with no specific catalyst identified.

  • A news report covering the stock’s recent activity also did not attribute its earlier price move to a specific cause.
  • Biotech-sector strength was noted earlier, but no direct cause was confirmed; broader U.S. indices declined.
  • After-hours trading volume was unavailable in the reviewed sources.